Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Cancer Institute and Hospital, Chinese Academy of Medical Sciences)"
Count: 137
Selected: 0
| NCT ID | Title |
|---|
| NCT05345860 | Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer | ||
| NCT04125849 | Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Cancer | ||
| NCT04389073 | Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine | ||
| NCT02691871 | Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR | ||
| NCT04498793 | Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer | ||
| NCT03392220 | A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer | ||
| NCT04850027 | MRI-guided Lateral Lymph Node Dissection in Rectal Cancer | ||
| NCT03772496 | Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells) | ||
| NCT02933294 | Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer | ||
| NCT04099589 | Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma | ||
| NCT05331326 | A Study of RC48-ADC for the Treatment of HER2-expression Metastatic Breast Cancer With Abnormal Activation of PAM Pathway | ||
| NCT05327517 | Surgery or Chemoradiotherapy for Cervical Esophageal Cancer | ||
| NCT05289726 | Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105 | ||
| NCT05283616 | Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer | ||
| NCT05188859 | First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma | ||
| NCT05167149 | Carbon Nanoparticles and Indocyanine Green for Sentinel Lymph Node Biopsy in Early Stage Cervical Cancer | ||
| NCT05009017 | Multi-Centre, Observational Study on Safety of Bevacizumab Biosimilars in Clinical Practice Among Chinese Patients | ||
| NCT04972201 | A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy | ||
| NCT04970043 | Camrelizumab Combined With Pemetrexed and Carboplatin for the Study of EGFR-mutated Lung Squamous NSCLC Treatment | ||
| NCT04850040 | A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and Oxaliplatin | ||
| NCT04822792 | Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT | ||
| NCT04506242 | Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer | ||
| NCT04500717 | Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Mutation | ||
| NCT04500704 | Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC | ||
| NCT04423185 | PLATFORM Study of Precision Medicine for Rare Tumors | ||
| NCT04213937 | Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer | ||
| NCT04068090 | Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer | ||
| NCT03839550 | Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection | ||
| NCT03775928 | Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer | ||
| NCT03575806 | Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection | ||
| NCT03383562 | Daytime Variation of Complication in Gastric and Pancreatic Surgery | ||
| NCT03291574 | Perioperative Electroacupuncture for Gastric Cancer Patients After Gastrectomy | ||
| NCT03291561 | Perioperative Electroacupuncture After Operation | ||
| NCT03137368 | A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP） | ||
| NCT03016364 | Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain | ||
| NCT03009253 | Translational Research on Locally Advanced Pancreatic Adenocarcinoma | ||
| NCT02992353 | Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer | ||
| NCT02989259 | Apatinib for Advanced Non-squamous Head and Neck Cancer | ||
| NCT02981641 | IORT Versus CCRT for Pancreatic Cancer | ||
| NCT02943252 | The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer | ||
| NCT02861196 | Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer | ||
| NCT02734680 | IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer | ||
| NCT02635503 | Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer | ||
| NCT02688023 | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer | ||
| NCT02646735 | Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients | ||
| NCT01024712 | Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT03751592 | Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer | ||
| NCT04769388 | Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L Osimertinib | ||
| NCT02361112 | Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer | ||
| NCT01994213 | A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumor |
